Advertisement
(Logo: http://www.newscom.com/cgi-bin/prnh/20030429/KNDLLOGO )
Kendle is among the world's leading global clinical research organizationsand is the fourth-largest provider of Phase II-IV clinical developmentservices worldwide. The company delivers innovative and robust clinicaldevelopment solutions - from first-in-human studies through market launch andsurveillance - to help the world's biopharmaceutical companies maximizeproduct life cycles and grow market share. Kendle's global clinicaldevelopment business is focused on five regions - North America, Europe,Asia/Pacific, Latin America and Africa - to meet customer needs. With theexpertise of its more than 3,000 associates worldwide, Kendle has conductedclinical trials and provided regulatory and pharmacovigilance services in morethan 80 countries. The company was named the "Top CRO to Work With" in theThomson CenterWatch 2007 Survey of U.S. Investigative Sites. For moreinformation, please visit http://www.kendle.com/.
Advertisement
To read the complete press release of Kendle's 10-year anniversary as apublic company, please go to:http://www.kendle.com/media/news_releases/Kendle_10_Year_PCA%208_22_07.pdf
To access the archived Webcast and slide presentation from Kendle'sInvestor Day, please go to:http://www.videonewswire.com/event.asp?id=41930
To hear Chairman and CEO Candace Kendle, PharmD, talk with CNBC ReporterStacey Tisdale about Kendle's growth plans for the future, please go to:http://investor.shareholder.com/ceosignature/webcast.cfm?mediaid=27131&k=7460E32301E9A59BF6DDBDA9071EB9C7To view the Multimedia News Release, go to:http://www.prnewswire.com/mnr/kendle/29376/
SOURCE Kendle
